Sodium 4-aminobenzoate, also known as potassium para-aminobenzoate (PABA), is used mainly as a treatment for fibrotic skin conditions including Peyronie’s disease and scleroderma. It works by increasing oxygen uptake and softening fibrous tissue, which may help reduce the thickening or scarring of connective tissue. Additionally, it has been used as a dietary supplement, although its effectiveness for non-medical purposes is limited and not well-supported by scientific evidence. Its therapeutic use is listed as sunscreens. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Sodium 4-Aminobenzoate, p-Aminobenzoic acid and sodium salt. It is also listed for alternate use as: API Intermediate. Its PubChem CID is 517441.
Sodium 4-aminobenzoate
| CAS No | 555-06-6 |
|---|---|
| Molecular Formula | C7H6NNaO2 |
| Molecular Weight | 159.12 g/mol |
| Synonyms | sodium;4-aminobenzoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Sodium 4-aminobenzoate, also known as potassium para-aminobenzoate (PABA), is used mainly as a treatment for fibrotic skin conditions including Peyronie's disease and scleroderma.
The listed CAS number is 555-06-6.
The listed molecular formula is C7H6NNaO2.
The listed molecular weight is 159.12 g/mol.
sodium;4-aminobenzoate.
The source lists Sodium 4-Aminobenzoate, p-Aminobenzoic acid and sodium salt.